Sheikh Marie Naeem, MD | |
415 Boulevard, Mountain Lakes, NJ 07046-1723 | |
(973) 334-7700 | |
(973) 402-5847 |
Full Name | Sheikh Marie Naeem |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 53 Years |
Location | 415 Boulevard, Mountain Lakes, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932198538 | NPI | - | NPPES |
1301608 | Medicaid | NJ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | MA31250 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Morristown Medical Center | Morristown, NJ | Hospital |
Saint Clare's Hospital/ Denville Campus | Denville, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Practice Associates Medical Group | 5890703177 | 1116 |
News Archive
Carol Berkowitz, MD, and Mallory D. Witt, MD, lead researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, received the Serge & Yvette Dadone Clinical Teaching Award in Honor of Saleh Salehmoghaddam, M.D., a peer-reviewed recognition of their "outstanding dedication, innovation, and sustained excellence in clinical and classroom teaching," according to the David Geffen School of Medicine at UCLA, which presented the awards.
Our immune systems contain three fundamentally different types of cell: B-cells, T-cells and the mysteriously named Natural Killer cells (NK cells), which are known to be involved in killing tumour cells and other infected cells. Experiments to investigate the function of NK cells have proven difficult to interpret because the interactions between the various components of the immune system make it almost impossible to isolate effects of individual cell types.
"A vaccine against one of the most neglected yet fatal tropical diseases is being tested for the first time in a clinical trial in India and the U.S.," IRIN reports. Visceral leishmaniasis (VL), "also called kala-azar or black fever, infects an estimated half million persons or more annually," and "it is found most commonly in India, Nepal, Bangladesh, Brazil and Sudan," the news service notes.
A loss of $3.7 million in federal funds is forcing Georgia to reduce its workforce for HIV prevention. After an inquiry by Georgia Health News, the Department of Public Health this week acknowledged that 20 people in state health districts have been notified they will probably lose their jobs in January, and that an unspecified number of staffers at the department level have received the same notification.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
› Verified 5 days ago
Entity Name | Practice Associates Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
Carol Berkowitz, MD, and Mallory D. Witt, MD, lead researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, received the Serge & Yvette Dadone Clinical Teaching Award in Honor of Saleh Salehmoghaddam, M.D., a peer-reviewed recognition of their "outstanding dedication, innovation, and sustained excellence in clinical and classroom teaching," according to the David Geffen School of Medicine at UCLA, which presented the awards.
Our immune systems contain three fundamentally different types of cell: B-cells, T-cells and the mysteriously named Natural Killer cells (NK cells), which are known to be involved in killing tumour cells and other infected cells. Experiments to investigate the function of NK cells have proven difficult to interpret because the interactions between the various components of the immune system make it almost impossible to isolate effects of individual cell types.
"A vaccine against one of the most neglected yet fatal tropical diseases is being tested for the first time in a clinical trial in India and the U.S.," IRIN reports. Visceral leishmaniasis (VL), "also called kala-azar or black fever, infects an estimated half million persons or more annually," and "it is found most commonly in India, Nepal, Bangladesh, Brazil and Sudan," the news service notes.
A loss of $3.7 million in federal funds is forcing Georgia to reduce its workforce for HIV prevention. After an inquiry by Georgia Health News, the Department of Public Health this week acknowledged that 20 people in state health districts have been notified they will probably lose their jobs in January, and that an unspecified number of staffers at the department level have received the same notification.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Sheikh Marie Naeem, MD Po Box 416457, Boston, MA 02241-6457 Ph: (844) 362-1735 | Sheikh Marie Naeem, MD 415 Boulevard, Mountain Lakes, NJ 07046-1723 Ph: (973) 334-7700 |
News Archive
Carol Berkowitz, MD, and Mallory D. Witt, MD, lead researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, received the Serge & Yvette Dadone Clinical Teaching Award in Honor of Saleh Salehmoghaddam, M.D., a peer-reviewed recognition of their "outstanding dedication, innovation, and sustained excellence in clinical and classroom teaching," according to the David Geffen School of Medicine at UCLA, which presented the awards.
Our immune systems contain three fundamentally different types of cell: B-cells, T-cells and the mysteriously named Natural Killer cells (NK cells), which are known to be involved in killing tumour cells and other infected cells. Experiments to investigate the function of NK cells have proven difficult to interpret because the interactions between the various components of the immune system make it almost impossible to isolate effects of individual cell types.
"A vaccine against one of the most neglected yet fatal tropical diseases is being tested for the first time in a clinical trial in India and the U.S.," IRIN reports. Visceral leishmaniasis (VL), "also called kala-azar or black fever, infects an estimated half million persons or more annually," and "it is found most commonly in India, Nepal, Bangladesh, Brazil and Sudan," the news service notes.
A loss of $3.7 million in federal funds is forcing Georgia to reduce its workforce for HIV prevention. After an inquiry by Georgia Health News, the Department of Public Health this week acknowledged that 20 people in state health districts have been notified they will probably lose their jobs in January, and that an unspecified number of staffers at the department level have received the same notification.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
› Verified 5 days ago
Christopher Michael Tully, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 333 Route 46 W, Mountain Lakes, NJ 07046 Phone: 973-316-1701 Fax: 973-316-1708 | |
Ronald D Massari, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 356 Route 46 E, Mountain Lakes, NJ 07046 Phone: 973-586-3400 Fax: 973-586-1916 | |
Keith S Leibowitz, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 415 Boulevard, Mountain Lakes, NJ 07046 Phone: 973-334-7700 Fax: 973-402-5847 | |
Paul D Derenzi, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 415 Boulevard, Mountain Lakes, NJ 07046 Phone: 973-334-7700 Fax: 973-402-5847 | |
Philip S Rogers, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 415 Boulevard, Mountain Lakes, NJ 07046 Phone: 973-334-7700 Fax: 973-402-5847 | |
Hyeun S Park, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 415 Boulevard, Mountain Lakes, NJ 07046 Phone: 973-334-7700 Fax: 973-334-7116 | |
Dr. Muhammad R. Abbasi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 333 Route 46 W, Mountain Lakes, NJ 07046 Phone: 973-316-1701 Fax: 973-316-1708 |